Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$302M |
| 2 |
Advanced Micro Devices
AMD
|
+$270M |
| 3 |
Cardinal Health
CAH
|
+$257M |
| 4 |
Adobe
ADBE
|
+$221M |
| 5 |
Visa
V
|
+$218M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$257M |
| 2 |
Bank of America
BAC
|
+$245M |
| 3 |
Stanley Black & Decker
SWK
|
+$240M |
| 4 |
Coca-Cola
KO
|
+$232M |
| 5 |
Cisco
CSCO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.38% |
| 2 | Healthcare | 15.51% |
| 3 | Financials | 12.11% |
| 4 | Consumer Discretionary | 11.09% |
| 5 | Industrials | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
1351
DELISTED
Sage Therapeutics
SAGE
| $97K | ﹤0.01% |
2,758
| – | – |
|
1352
dLocal
DLO
$4.26B
| $96K | ﹤0.01% |
3,986
-717
| -15% | -$18.4K |
|
1353
Palomar
PLMR
$3.65B
| $95K | ﹤0.01% |
1,675
-7,754
| -82% | -$468K |
|
1354
Atkore
ATKR
$2.59B
| $94K | ﹤0.01% |
1,145
+437
| +62% | +$43.4K |
|
1355
Interactive Brokers
IBKR
$40.9B
| $94K | ﹤0.01% |
7,072
-20,288
| -74% | -$301K |
|
1356
MannKind Corp
MNKD
$1.28B
| $94K | ﹤0.01% |
+24,407
| New | +$89.7K |
|
1357
Advantage Solutions
ADV
$484M
| $93K | ﹤0.01% |
945
-461
| -33% | -$55.7K |
|
|
BWIN
1358
Baldwin Insurance Group
BWIN
$2.58B
| $93K | ﹤0.01% |
3,982
| – | – |
|
|
JHG
1359
DELISTED
Janus Henderson
JHG
| $92K | ﹤0.01% |
3,919
+1,215
| +45% | +$34.9K |
|
1360
SkinHealth Systems
SKIN
$94.9M
| $92K | ﹤0.01% |
+7,278
| New | +$97.5K |
|
|
LOGC
1361
DELISTED
ContextLogic
LOGC
| $92K | ﹤0.01% |
2,067
| – | – |
|
1362
InMode
INMD
$872M
| $90K | ﹤0.01% |
3,330
-5,349
| -62% | -$141K |
|
1363
Pricesmart
PSMT
$5.75B
| $90K | ﹤0.01% |
1,352
-539
| -29% | -$41.8K |
|
1364
Vanguard S&P 500 Growth ETF
VOOG
$25.4B
| $90K | ﹤0.01% |
2,430
| – | – |
|
1365
Commercial Metals
CMC
$7.63B
| $89K | ﹤0.01% |
2,673
-14,044
| -84% | -$553K |
|
|
CVAC
1366
DELISTED
CureVac
CVAC
| $87K | ﹤0.01% |
+6,870
| New | +$114K |
|
|
XM
1367
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $87K | ﹤0.01% |
6,831
-9,743
| -59% | -$173K |
|
1368
ABM Industries
ABM
$2.8B
| $86K | ﹤0.01% |
2,041
-38
| -2% | -$1.76K |
|
1369
BioCryst Pharmaceuticals
BCRX
$2.37B
| $86K | ﹤0.01% |
+7,471
| New | +$77.1K |
|
1370
Iovance Biotherapeutics
IOVA
$2.23B
| $86K | ﹤0.01% |
6,781
-1,503
| -18% | -$19.7K |
|
1371
Vanguard S&P 500 Value ETF
VOOV
$6.58B
| $86K | ﹤0.01% |
655
| – | – |
|
1372
Madrigal Pharmaceuticals
MDGL
$12.6B
| $85K | ﹤0.01% |
+1,249
| New | +$91.8K |
|
1373
PENN Entertainment
PENN
$2.74B
| $85K | ﹤0.01% |
2,926
-598
| -17% | -$20.2K |
|
1374
Super Micro Computer
SMCI
$19.5B
| $85K | ﹤0.01% |
20,630
-8,250
| -29% | -$37.6K |
|
1375
Pacific Biosciences
PACB
$422M
| $84K | ﹤0.01% |
18,108
+17,725
| +4,628% | +$108K |
|
Similar funds
Amundi's Q2 2022 Portfolio in Review
As of Q2 2022, Amundi held 1,750 positions worth $125B, down 16% from $148B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Amundi's Q2 2022 filing shows 104 new, 631 increased, 657 reduced and 91 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 188,190 shares worth $71.5M. The largest sale was Procter & Gamble, an estimated $257M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Amundi's largest Q2 2022 buy was iShares Core S&P 500 ETF: 188,190 shares worth $71.5M.
- Amundi added most to Freeport-McMoran in Q2 2022, an estimated $302M increase.
- Amundi's biggest Q2 2022 reduction was Procter & Gamble, cutting an estimated $257M.
- Amundi fully exited Cerner Corp in Q2 2022, selling an estimated $152M.
- Amundi's ten largest holdings make up 18% of its $125B portfolio in Q2 2022.
- Amundi opened 104 new positions and closed 91 in Q2 2022.
- Amundi's portfolio value fell 16% quarter-over-quarter to $125B.
Based on Amundi's 13F filing for Q2 2022, filed 15 Aug 2022.